• Explore /
  • Poster
  • / Livmoniplimab with or without budigalimab in patients with advanced solid tumors: Results from the combination therapy in the urothelial carcinoma dose expansion cohort.

Livmoniplimab with or without budigalimab in patients with advanced solid tumors: Results from the combination therapy in the urothelial carcinoma dose expansion cohort.

Abstract Video & Slides Poster

Authors

null

Desamparados Roda

Hospital Clínico Universitario-INCLIVIA, Valencia, Spain

Desamparados Roda , Jean-Pascal H. Machiels , Chang-Fang Chiu , Shunsuke Kondo , Victor Ricardo Adorno Febles , Victor Moreno , Chia-Chi Lin , Sun Young Young Rha , Sarid David , Albiruni Ryan Abdul Razak , Steven Chuan-Hao Kao , Maulik Patel , Mohammad Sahtout , Jonathan Deutsch , Duyen Ngo , Cristiano Ferlini , Kai He

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Urothelial Carcinoma

Track

Urothelial Carcinoma

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03821935

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 617)

DOI

10.1200/JCO.2024.42.4_suppl.617

Abstract #

617

Poster Bd #

H2

Abstract Disclosures

Similar Posters

First Author: Arlene O. Siefker-Radtke

First Author: Panpan Zhang

First Author: Jiaxin Niu

First Author: Judy S. Wang